文献速递肿瘤 PET/CT甲状腺核医学核素与放射性配体治疗

伴侣动物核医学:犬猫转化证据图谱

Companion animal nuclear medicine: A translational evidence map for dogs and cats.
PubMed 文献 · Semin Nucl Med · 2026-10-28

本文通过PRISMA系统证据图谱综述了犬猫核医学影像与放射性核素治疗文献,纳入228篇文章,以影像为主。猫核医学集中于甲状腺疾病,犬核医学范围更广,涵盖肿瘤PET/CT、骨肉瘤、肾肝胆功能显像等,最成熟模型为猫甲状腺显像与放射性碘治疗。

要点

  • 猫核医学最成熟应用为甲状腺显像和放射性碘治疗甲亢。
  • 犬核医学应用更广,PET/CT在犬肿瘤学中最突出。
  • 伴侣动物核医学与人类核医学具有转化相关性。

核心结论

  • 伴侣动物核医学具有临床实用性和转化相关性,最成熟模型为猫甲状腺显像与放射性碘治疗,最具动态前景的方向在犬肿瘤学、分子影像和放射诊疗一体化。

研究设计与样本

  • 采用PRISMA对齐的系统证据图谱并辅以聚焦叙述性综合,检索MEDLINE via PubMed和Web of Science Core Collection,补充Google Scholar检索、参考文献筛选和引文挖掘,共纳入228篇文章。

主要发现

  • 文献以影像为主,176篇仅涉及影像,34篇仅涉及治疗,18篇同时涉及影像与治疗。
  • 猫核医学以甲状腺疾病为主,尤其是甲状腺显像和放射性碘治疗甲亢。
  • 犬核医学范围更广,包括肿瘤PET/CT、骨肉瘤显像与治疗、肾和肝胆功能闪烁显像、门体分流显像、神经/行为显像、甲状腺癌和放射滑膜切除术。
  • PET/CT在犬肿瘤学中最突出,传统闪烁显像在功能信息无法被结构影像替代时仍重要。

临床怎么用

  • 猫甲亢可参考甲状腺显像和放射性碘治疗的成熟应用模式。
  • 犬肿瘤学中PET/CT应用最突出,传统闪烁显像在需要功能信息时仍有价值。
  • 兽医专科与人类核医学专业人员更紧密合作可能改善伴侣动物诊疗并促进分子影像和靶向放射性核素治疗发展。

局限性

  • 因物种、适应证、放射性药物、方案、对照和结局报告异质性,未进行正式meta分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Companion animals occupy an increasingly important clinical and societal space, with dogs and cats often managed as family members and receiving advanced diagnostic and therapeutic care. Many veterinary nuclear medicine procedures are adapted from human practice, while naturally occurring canine and feline diseases provide opportunities for comparative and translational insight. This review mapped and synthesised the literature on nuclear medicine imaging and radionuclide therapy in dogs and cats, with emphasis on clinically mature applications and relevance to human nuclear medicine. A PRISMA-aligned systematic evidence map with focused narrative synthesis were undertaken. MEDLINE via PubMed and Web of Science Core Collection were searched, with supplementary Google Scholar searching, reference-list screening and citation mining. Because of heterogeneity in species, indication, radiopharmaceutical, protocol, comparator and outcome reporting, formal meta-analysis was not performed. A total of 228 articles were included. The literature was predominantly imaging-focused, with 176 articles addressing imaging alone, 34 therapy alone and 18 both imaging and therapy. Feline nuclear medicine was dominated by thyroid disease, particularly thyroid scintigraphy and radioiodine therapy for hyperthyroidism. Canine nuclear medicine was broader, including oncology PET/CT, osteosarcoma imaging and therapy, renal and hepatobiliary functional scintigraphy, portosystemic shunt imaging, neurology/behavioural imaging, thyroid carcinoma and radiosynoviorthesis. PET/CT was most prominent in canine oncology, while conventional scintigraphy remained important where functional information could not be replaced by structural imaging. Companion animal nuclear medicine is clinically useful and translationally relevant. Its most mature model is feline thyroid scintigraphy and radioiodine therapy, while its most dynamic future directions lie in canine oncology, molecular imaging and radiotheranostics. Closer collaboration between veterinary specialists and human nuclear medicine professionals may improve companion animal care while informing broader development of molecular imaging and targeted radionuclide therapy.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Becker, Tually, Currie, et al. Companion animal nuclear medicine: A translational evidence map for dogs and cats. Semin Nucl Med. 2026. PMID: 42951719. doi:10.1053/j.semnuclmed.2026.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。